Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays

被引：75

作者：

Clark, J

Edwards, S

Feber, A

Flohr, P

John, M

Giddings, I

Crossland, S

Stratton, MR

Wooster, R

Campbell, C

Cooper, CS ^{[1
]}

机构：

[1] Inst Canc Res, Male Urol Canc Res Ctr, Mol Carcinogenesis Sect, Surrey, England

[2] Inst Canc Res, Male Urol Canc Res Ctr, Canc Res UK DNA Microarray Facil, Surrey, England

[3] Wellcome Trust Sanger Inst, Cambridge, England

[4] Univ Bristol, Adv Comp Res Ctr, Bristol BS8 1TH, Avon, England

来源：

ONCOGENE | 2003年 / 22卷 / 08期

关键词：

D O I：

10.1038/sj.onc.1206247

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We demonstrate that comparative genomic hybridization (CGH) onto cDNA microarrays may be used to carry out genome-wide screens for regions of genetic loss, including homozygous (complete) deletions that may represent the possible location of tumour suppressor genes in human cancer. Screening of the prostate cancer cell lines LNCaP, PC3 and DU145 allowed the mapping of specific regions where genome copy number appeared altered and led to the identification of two novel regions of complete loss at 17q21.31 (500 kb spanning STAT3) and at 10q23.1 (50-350 kb spanning SFTPA2) in the PC3 cell line.

引用

页码：1247 / 1252

页数：6

共 50 条

[31] Genome-wide screening of genes associated with chemosensitivity of human cancer xenografts by means of cDNA microarray.
Zembutsu, H
Tsunoda, T
Furukawa, Y
Ohnishi, Y
Katagiri, T
Okutsu, J
Ueyama, Y
Tamaoki, N
Hirata, K
Nakamura, Y
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 259 - 259
[32] Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors
Veltman, JA
Fridlyand, J
Pejavar, S
Olshen, AB
Korkola, JE
DeVries, S
Carroll, P
Kuo, WL
Pinkel, D
Albertson, D
Cordon-Cardo, C
Jain, AN
Waldman, FM
CANCER RESEARCH, 2003, 63 (11) : 2872 - 2880
[33] Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors
Veltman, JA
Korkola, JE
Pejavar, S
Koppie, TM
Fridlyand, J
Olshen, AB
Carroll, PR
Cordon-Cardo, C
Kuo, WL
Pinkel, D
Albertson, DG
Jain, A
Waldman, FM
CYTOMETRY, 2002, : 30 - 30
[34] Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome
Palmieri, Orazio
Mazzoccoli, Gianluigi
Bossa, Fabrizio
Maglietta, Rosalia
Palumbo, Orazio
Ancona, Nicola
Corritore, Giuseppe
Latiano, Tiziana
Martino, Giuseppina
Rubino, Rosa
Biscaglia, Giuseppe
Scimeca, Daniela
Carella, Massimo
Annese, Vito
Andriulli, Angelo
Latiano, Anna
CHRONOBIOLOGY INTERNATIONAL, 2015, 32 (07) : 903 - 916
[35] Cancer genetic association studies in the genome-wide age
Savage, S. A.
PERSONALIZED MEDICINE, 2008, 5 (06) : 589 - 597
[36] Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss
Liu, Xijuan
Simon, Jeremy M.
Xie, Haibiao
Hu, Lianxin
Wang, Jun
Zurlo, Giada
Fan, Cheng
Ptacek, Travis S.
Herring, Laura
Tan, Xianming
Li, Mingjie
Baldwin, Albert S.
Kim, William Y.
Wu, Tao
Kirschner, Marc W.
Gong, Kan
Zhang, Qing
MOLECULAR CELL, 2020, 77 (06) : 1294 - +
[37] Uncovering somatic genetic susceptibility factors in prostate cancer through comprehensive genome-wide analysis
Lin, L.
Wu, K.
Li, X.
EUROPEAN UROLOGY, 2024, 85 : S235 - S235
[38] Genetic susceptibility of prostate cancer: genome-wide screen of men with non-aggressive disease
Christensen, G. B.
Camp, N. J.
Farnham, J. M.
Cannon-Albright, L. A.
GENETIC EPIDEMIOLOGY, 2007, 31 (05) : 467 - 468
[39] UNCOVERING SOMATIC GENETIC SUSCEPTIBILITY FACTORS IN PROSTATE CANCER THROUGH COMPREHENSIVE GENOME-WIDE ANALYSIS
Lin, Lede
Wu, Kan
Li, Xiang
JOURNAL OF UROLOGY, 2024, 211 (05): : E673 - E673
[40] Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study
Kim, Y. S.
Kim, Y.
Choi, J. W.
Oh, H. E.
Lee, J. H.
NEOPLASMA, 2016, 63 (04) : 629 - 634

← 1 2 3 4 5 →